Profund Advisors LLC Ironwood Pharmaceuticals Inc Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Profund Advisors LLC holds 82,369 shares of IRWD stock, worth $284,173. This represents 0.01% of its overall portfolio holdings.

Number of Shares

82,369

Previous 75,383 9.27%

Holding current value

$284,173

Previous $491,000 31.16%

% of portfolio

0.01%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.93 - $7.04 $27,454 - $49,181	6,986 Added 9.27%	82,369 $338,000
Q2 2024 Aug 13, 2024	SELL	$5.58 - $8.61 $482,513 - $744,523	-86,472 Reduced 53.43%	75,383 $491,000
Q1 2024 May 08, 2024	BUY	$8.32 - $15.45 $352,526 - $654,631	42,371 Added 35.46%	161,855 $1.41 Million
Q4 2023 Feb 14, 2024	SELL	$8.79 - $11.51 $279,478 - $365,960	-31,795 Reduced 21.02%	119,484 $1.37 Million
Q3 2023 Nov 13, 2023	BUY	$8.25 - $11.35 $117,966 - $162,293	14,299 Added 10.44%	151,279 $1.46 Million
Q2 2023 Aug 10, 2023	BUY	$10.1 - $11.6 $156,398 - $179,626	15,485 Added 12.75%	136,980 $1.46 Million
Q1 2023 May 11, 2023	BUY	$10.37 - $12.56 $1.07 Million - $1.3 Million	103,109 Added 560.8%	121,495 $1.28 Million
Q4 2022 Feb 02, 2023	BUY	$9.9 - $12.43 $1,791 - $2,249	181 Added 0.99%	18,386 $227,000
Q3 2022 Nov 04, 2022	SELL	$10.14 - $12.38 $33,685 - $41,126	-3,322 Reduced 15.43%	18,205 $189,000
Q2 2022 Aug 01, 2022	BUY	$11.05 - $12.72 $80,234 - $92,359	7,261 Added 50.9%	21,527 $248,000
Q1 2022 May 10, 2022	SELL	$10.61 - $12.88 $10,249 - $12,442	-966 Reduced 6.34%	14,266 $179,000
Q4 2021 Feb 08, 2022	BUY	$10.86 - $13.95 $7,200 - $9,248	663 Added 4.55%	15,232 $178,000
Q3 2021 Nov 12, 2021	SELL	$11.92 - $13.92 $18,893 - $22,063	-1,585 Reduced 9.81%	14,569 $190,000
Q2 2021 Aug 12, 2021	BUY	$10.16 - $13.11 $7,741 - $9,989	762 Added 4.95%	16,154 $208,000
Q1 2021 May 14, 2021	BUY	$9.04 - $11.86 $8,389 - $11,006	928 Added 6.42%	15,392 $172,000
Q4 2020 Feb 09, 2021	BUY	$9.05 - $12.2 $6,651 - $8,967	735 Added 5.35%	14,464 $165,000
Q3 2020 Nov 13, 2020	SELL	$8.99 - $10.74 $6,499 - $7,765	-723 Reduced 5.0%	13,729 $123,000
Q2 2020 Aug 03, 2020	BUY	$9.14 - $11.97 $8,527 - $11,168	933 Added 6.9%	14,452 $149,000
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $17,494 - $28,566	-2,039 Reduced 13.11%	13,519 $136,000
Q4 2019 Feb 18, 2020	BUY	$8.22 - $14.0 $22,826 - $38,878	2,777 Added 21.73%	15,558 $207,000
Q3 2019 Nov 12, 2019	SELL	$8.59 - $10.96 $15,084 - $19,245	-1,756 Reduced 12.08%	12,781 $110,000
Q2 2019 Aug 13, 2019	BUY	$9.8 - $12.89 $5,203 - $6,844	531 Added 3.79%	14,537 $159,000
Q1 2019 May 15, 2019	SELL	$8.27 - $12.73 $74,049 - $113,984	-8,954 Reduced 39.0%	14,006 $190,000
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $28,906 - $59,777	-3,706 Reduced 13.9%	22,960 $238,000
Q3 2018 Nov 13, 2018	BUY	$14.31 - $17.65 $381,590 - $470,654	26,666 New	26,666 $492,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $529M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Ironwood Pharmaceuticals Inc Transaction History